Keyphrases
Regulatory T (Treg) Cells
100%
Interferon-β (IFN-β)
80%
Forkhead Box A1 (FOXA1)
80%
Interferon-α (IFN-α)
71%
Regulatory T Cells
56%
CD1d
53%
NKT Cells
53%
AKT1
53%
Programmed Death-ligand 1 (PD-L1)
41%
Inflammation
35%
Protective Behavior
35%
IFNAR1
35%
Interferon Signaling
29%
MCF-7
26%
Interleukin-4 (IL-4)
26%
Arthritis Models
26%
Glioblastoma
26%
Tumor
26%
Chronic Arthritis
26%
Oral Tolerance
26%
Better Prognosis
26%
Immunosuppressive Properties
26%
T Cell Subpopulations
26%
Parkinson's Disease
26%
PD-L1 Expression
26%
Breast Cancer Cells
26%
Anti-inflammatory Properties
26%
Autophagy
26%
Acute Arthritis
26%
Activation Capacity
26%
Natural Immunomodulators
26%
Th1 Response
26%
Pro-apoptotic
26%
Dementia
26%
Antigen-specific
26%
Treg
19%
Neurodegeneration
17%
Alpha-synuclein (α-syn)
17%
Neurodegenerative Diseases
17%
Arthritis
16%
Collagen-induced Arthritis
16%
Transient MCAO
16%
Immunology and Microbiology
Regulatory T Cell
60%
Natural Killer T Cell
53%
Peptides
53%
Antigen Specificity
40%
Interferon
39%
Experimental Autoimmune Encephalomyelitis
37%
T Cell
34%
Arthritis
32%
Interleukin 4
26%
Autophagy
26%
Antigen-Presenting Cell
26%
Cancer Cell
26%
Beta Interferon
26%
Immunomodulating Drug
26%
Neuroscience
Interferon
85%
Cerebrovascular Accident
39%
Glioblastoma Multiforme
26%
Brain Ischemia
26%
Immunomodulating Drug
26%
Beta Interferon
26%
Anti-Inflammatory
26%
Dementia with Lewy Body
26%
Parkinson's Disease
26%
Protein Kinase B
26%
T Cell
19%
Experimental Autoimmune Encephalomyelitis
16%